Europe Smart Pills Drug Delivery Market - Size
Base Year For Estimation
2023
Forecast Data Period
2024-2030
Historical Data Period
2018-2021
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
Smart pills or nootropics are small medical and embedded electronic devices such as sensors, cameras, and trackers which can be quickly swallowed and provides a complete evaluation of the gastrointestinal tract. Drug delivery is an approach, technology or a system for transporting medicine inside the body via drug chemical and by drug-device products. Smart pills have reduced the difference between digital and healthcare technology. However, real-time patient monitoring is possible with intelligent pills diagnostics and can record bodily functions of the patients.
Europe Smart Pills Drug Delivery Market Segments Size & Growth:
Europe Smart Pills Drug Delivery Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are due to the prevalence of Gastro-Intestinal diseases; it reduces invasive surgeries, technological developments in capsule endoscopy, personalised medicine, and reimbursement policies. However, lack of skilled professionals, expensive treatment, and
Europe Smart Pills Drug Delivery Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
ethical issues hinder the growth of the Europe smart pills drug delivery market.
Europe Smart Pills Drug Delivery Market Segments Share:
Europe Smart Pills Drug Delivery Market is categorised into by type which consists ofIntelliCap CR and IntelliCap FR. IntelliCap FR has the most significant share due to its design capabilities for use in clinical trials for drug delivery in the gastrointestinal tract, along with recording conditions in the body. IntelliCap FR delivers the drug in the form of solids, powder, and semi-solid into the patient’s body.
By Geography, Germany is dominating the smart pills drug delivery market, and the growth in Europe is mainly attributed because of the increasing non-invasive diagnosis and advancement personalised medicine. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising ageing population, awareness about GI tract and demand for precision medicine.
Europe Smart Pills Drug Delivery Market Segments Trends:
- In November 2016, research of MIT and Brigham has manufactured a new
You can also purchase parts of this report. Do you want to check out a section wise price list
Europe Smart Pills Drug Delivery Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
capsule that remains for a long-term and slowly delivery its drug to overcome problems will treatment and curing diseases like malaria.
In March 2017, Boston Scientific Corporation acquired Symetis SA this will help expand valvular heart treatment for some patients.
Europe Smart Pills Diagnostics Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- AdhereTech
- IntroMedic Co., Ltd.,
- GE Healthcare
- MicroChips
- Boston Scientific Corporation
Exclusive Benefits
Credibility and
Transparency
We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.
Exhaustive
Coverage
Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.
Competitive
Edge
Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.
Golden
pportunities
Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.
Top-notch Reportsd
Guaranteed
Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.
Post Purchase
Support
Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.